Objectives: Clostridium difficile infection (CDI) is still a major challenge to healthcare facilities. The 23 detection of multiple C. difficile strains has been reported in some patient samples during initial and 24 recurrent CDI episodes. However, the behaviour of individual strains and their contribution to 25 symptomatic disease is unclear. 26
Introduction

44
Clostridium difficile infection (CDI) continues to pose a major burden on healthcare facilities 45 worldwide. 1 The pathogenesis and interaction of individual strains within a multi-strain CDI is not well 59 understood. We recently demonstrated the germination and proliferation of two distinct C.
60
difficile isolates within a human gut model, 7 indicating that multiple strains may contribute 61 to disease in an in vitro model system. However, response to treatment and possible 62 infection recrudescence was not examined. We have now re-studied the C. difficile isolates 
Methods
Clostridium difficile strains 68
We examined two C. difficile PCR ribotype 001 strains (11/11 and P62). Both strains were clinical 69 isolates from cytotoxin-positive faeces of patients with CDI at Leeds General Infirmary, UK. Isolate The use of a triple stage model of the human to gut to study CDI has previously been described.
8-10
77
This model has been validated against physicochemical and microbiological measurements of the 78 intestinal contents of sudden death victims, 11 and comprises three chemostat glass vessels (Soham 79 Scientific, Cambridge, UK) (V1 280 mL; V2 300 mL; V3 300 mL), connected in a weir cascade 80 formation, top-fed with a complex growth medium 7 (flow rate = 13.2ml/h), maintained in an 81
anaerobic atmosphere and at a controlled pH (V1 pH 5.5 ± 0.2; V2 pH 6.2 ± 0.2; V3 pH 6.8 ± 0.2). 82
Each vessel is inoculated with a C. difficile-negative, pooled human faecal emulsion, donated from 83 healthy adult volunteers (n = 5, aged .
12 84 85
Experimental design 86
The experimental design is outlined in Figure 1 . After inoculation of the faecal emulsion into the gut 87 model (day 0 period A), the media pump was started and no interventions were made until C. 88 difficile CD-RM (~ 10 7 cfu) and CD-CR (~ 10 7 cfu) spores were inoculated into vessel 1 on day 14 89 (period B). After seven days (day 21) a further inoculum of C. difficile CD-RM and CD-CR spores were 90 added to vessel 1, along with 150 mg/L ceftriaxone, once daily, for seven days (period C) to induce 91 simulated CDI. Ceftriaxone instillation was designed to reflect concentrations observed in faeces of 92 volunteers. 13 Once high level cytotoxin was detected within the model (indicating simulated CDI), 93 instillation of vancomycin commenced (125 mg/L, four times daily, seven days period E). No 94 interventions were made for a further 21 days (period F). Indigenous gut microbiota (periods A-F, 95 vessels 2 and 3), C. difficile total viable counts, spores and cytotoxin (periods B-F, vessels 3), and antimicrobial activity (periods C-F, vessels 1-3) were monitored daily (every 2-days 97 period A only).
99
Enumeration of gut microbiota and C. difficile populations and cytotoxin 100
Gut microbiota populations were identified and enumerated, using selective and non-selective agars 101 as described previously.
14 Cultures were plated onto solid media in triplicate and average 102 populations (±standard error) obtained. C. difficile isolates were distinguished by culture onto 103 antimicrobial-containing CCEYL. CD-CR was isolated on CCEYL containing 8 mg/L clindamycin 104 (growth of CD-RM was inhibited) and CD-RM was isolated on CCEYL containing 1 mg/L 105 metronidazole (growth of CD-CR was inhibited). C. difficile spores were enumerated after alcohol 106 shock. 9 Cytotoxin was quantified using Vero cell cytotoxin assay. 
Results
124
Gut microbiota populations 125
Vessel 3 is of most physiological relevance for CDI, and therefore data from this vessel are to germinate nine and 11 days after vancomycin cessation, respectively. CR-RM total counts 153 peaked at ~6.5 log 10 cfu/mL before declining to ~5.5 log 10 cfu/mL. CD-RM spore populations 154 remained at ~3.5 log 10 cfu/mL for the remainder of the experiment. CD-CR total cells peaked 155 at a population of ~5 log 10 cfu/mL before declining to ~3.5 log 10 cfu/mL, with only spores 
